Wolverine Trading
BIO icon

Wolverine Trading’s Bio-Rad Laboratories Class A BIO Stock Holding History

Wolverine Trading’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,000
Closed -$486K – 4785
2025
Q1 		$486K Buy
+2,000
New +$602K ﹤0.01% 2990
2024
Q4 		– Sell
-1,900
Closed -$630K – 5271
2024
Q3 		$630K Buy
1,900
+100
+6% +$31.8K ﹤0.01% 2830
2024
Q2 		$492K Buy
1,800
+600
+50% +$175K ﹤0.01% 2873
2024
Q1 		$415K Buy
+1,200
New +$395K ﹤0.01% 3029
2023
Q4 		– Sell
-800
Closed -$287K – 4493
2023
Q3 		$287K Buy
+800
New +$309K ﹤0.01% 3336
2023
Q2 		– Sell
-900
Closed -$425K – 4256
2023
Q1 		$425K Buy
900
+100
+13% +$46.8K ﹤0.01% 2658
2022
Q4 		$336K Buy
+800
New +$323K ﹤0.01% 2669
2021
Q4 		– Sell
-900
Closed -$674K – 5880
2021
Q3 		$674K Buy
+900
New +$674K ﹤0.01% 3523
2021
Q2 		– Sell
-600
Closed -$338K – 5997
2021
Q1 		$338K Sell
600
-200
-25% -$118K ﹤0.01% 4298
2020
Q4 		$460K Buy
+800
New +$456K ﹤0.01% 3268
2020
Q3 		– Sell
-800
Closed -$346K – 4496
2020
Q2 		$346K Sell
800
-2,700
-77% -$1.19M ﹤0.01% 3154
2020
Q1 		$1.22M Buy
3,500
+2,700
+338% +$993K ﹤0.01% 1749
2019
Q4 		$296K Sell
800
-2,100
-72% -$740K ﹤0.01% 3604
2019
Q3 		$969K Buy
2,900
+1,600
+123% +$522K ﹤0.01% 2021
2019
Q2 		$406K Sell
1,300
-2,500
-66% -$749K ﹤0.01% 2938
2019
Q1 		$1.16M Buy
+3,800
New +$1.03M ﹤0.01% 1936
2018
Q4 		– Sell
-900
Closed -$282K – 4422
2018
Q3 		$282K Buy
+900
New +$279K ﹤0.01% 3807
2016
Q4 		– Sell
-2,100
Closed -$340K – 4437
2016
Q3 		$340K Buy
+2,100
New +$319K ﹤0.01% 3049

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

Wolverine Trading's BIO Position: Q4 2021 in Review

Wolverine Trading sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2021, closing a stake of 1,920 shares — an estimated $1.44M sold.

Wolverine Trading first reported a position in BIO in Q3 2016 and held it in 6 quarters. The position peaked at $1.44M in Q3 2021. 533 funds tracked by Wall St. Rank hold BIO as of Q4 2021.

  • Wolverine Trading reported no remaining Bio-Rad Laboratories Class A position as of Q4 2021 after selling out during the quarter.
  • Wolverine Trading sold 1,920 Bio-Rad Laboratories Class A shares in Q4 2021, an estimated $1.44M.
  • Wolverine Trading first reported a position in Bio-Rad Laboratories Class A in Q3 2016 and held it in 6 quarters.
  • Wolverine Trading's Bio-Rad Laboratories Class A position peaked at $1.44M in Q3 2021.
  • 533 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.